Noopept
Dipeptide GVS-111. Studied for BDNF/NGF modulation, neuroprotection, and cognitive enhancement.
Index entry
Research context
Dipeptide GVS-111. Studied for BDNF/NGF modulation, neuroprotection, and cognitive enhancement.
How to read this entry
The current evidence grade is Phase I / II. It describes the strongest verified research stage represented in the record; it is not a statement of safety, efficacy or suitability for use.
Editorial scope
This entry is an evidence index, not medical guidance. Detailed mechanisms, open questions and primary references can be added through the structured editorial importer as the record is reviewed.